ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms of Obesity: From Pathogenesis to Therapeutic Targets

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 July 2025 | Viewed by 803

Special Issue Editors


E-Mail Website
Guest Editor
Translational Endocrinology Group, Endocrinology Araea, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago (CHUS/SERGAS), Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain
Interests: obesity; leptin; metabolic syndrome; adiposity

E-Mail Website
Guest Editor
Grupo Fisiopatología Endocrina, Departamento de Endocrinología, Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo Hospitalario Universitario de Santiago (CHUS/SERGAS), Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain
Interests: hypertension; atherosclerosis; insulin resistance; biochemistry; neuroscience; metabolism; food chemistry; metabolic diseases; antioxidants; blood pressure

E-Mail Website
Guest Editor
Endocrine Physiopathology Group, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), 15706 Santiago de Compostela, Spain
Interests: nutrition; molecular biology; metabolism; insulin resistance; metabolic diseases; glucose; lipid metabolism; abdominal obesity; nutritional and metabolic diseases; body composition

Special Issue Information

Dear Colleagues,

Obesity is one of the most significant challenges in 21st century public health, and its study has become essential in understanding the complex interactions between genetic, metabolic, social, and environmental factors contributing to its development. In this regard, metabolic processes play a very important role in the development and maintenance of obesity, a condition that is characterized by both an increase in body fat and a profound reconfiguration of energy metabolism. These processes, which include feeding behavior, energy expenditure, locomotor activity, thermoregulation, lipid and glucose metabolism, and hormonal regulation, among others, help us to understand how obesity is perpetuated in different physiological and environmental scenarios. Obesity is currently a globally popular research topic, mainly due to the development of a new generation of drugs based on GLP-1 agonists; however, it is crucial we continue researching obesity to explore the underlying mechanisms that link it to metabolic disorders, and to open up new avenues for even more effective and personalized treatments. Therefore, this Special Issue welcomes original papers and reviews addressing molecular mechanisms that regulate the different pathologies associated with obesity.

Dr. Omar Al Massadi
Dr. Mar Quiñones
Dr. Luisa Maria Seoane
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • obesity
  • energy balance
  • type 2 diabetes
  • liver disease
  • adipose tissue
  • brain

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 4566 KiB  
Article
Fucoxanthin-Loaded Solid Lipid Nanoparticles Exert Potent Therapeutic Efficacy in Combating High-Fat Diet Induced Obesity in Mice
by Lijun Ding, Xiao Luo and Weijia Wen
Int. J. Mol. Sci. 2025, 26(11), 5249; https://doi.org/10.3390/ijms26115249 - 29 May 2025
Viewed by 463
Abstract
Obesity and associated metabolic disorders pose significant health challenges. Fucoxanthin, a lipophilic compound, has shown promising anti-obesity potential, but its poor solubility and bioavailability limit therapeutic efficacy. The successful formulation of solid lipid nanoparticles (SLNs) amplified fucoxanthin’s efficacy in mitigating obesity and the [...] Read more.
Obesity and associated metabolic disorders pose significant health challenges. Fucoxanthin, a lipophilic compound, has shown promising anti-obesity potential, but its poor solubility and bioavailability limit therapeutic efficacy. The successful formulation of solid lipid nanoparticles (SLNs) amplified fucoxanthin’s efficacy in mitigating obesity and the associated metabolic dysregulation. High-fat diet (HFD)-induced obese mice were treated with free fucoxanthin, lyophilized SLNs (L-SLN), and dispersed SLNs (D-SLN) loaded with fucoxanthin. The intervention with D-SLN demonstrated the most significant reduction in body weight gain (29.94%) and fat mass gain (61.80%) compared to the HFD group (p < 0.05), alongside notable improvements in metabolic indicators including fasting blood glucose, liver enzymes, lipid profile, and inflammatory markers such as leptin and monocyte chemoattractant protein 1 (MCP-1) levels. Histopathological evaluation corroborated these findings, showing highly reduced hepatic lipid droplet accumulation and improved adipocyte and testicular morphology. This advancement paved the way for translating fucoxanthin into a clinically effective anti-obesity agent. Full article
Show Figures

Figure 1

Back to TopTop